PMID: 37133Jan 1, 1979

A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice

The Journal of International Medical Research
R E Johnston, F Niesink


The long-term clinical effects of pipotiazine palmitate were tested in 206 men and women who were either not responding well to their previous neuroleptic therapy or who were negligent about pursuing protracted oral drug therapy. Of the 206 patients, 130 were suffering from some form of chronic schizophrenia; the remainder presented with depression, psychoneurotic or behavioural disorders. Pipotiazine palmitate, a long-acting depot neuroleptic, was given as a monthly intramuscular injection for up to 23 months. The average starting dose was 50 mg/injection and the average final dose was 65 mg/injection. These doses were somewhat lower than those usually reported in the literature, however all but a few patients received oral neuroleptics or antidepressants concomitantly. Psychiatric testing using the Brief Psychiatric Rating Scale revealed that significant improvement was achieved over time in all diagnostic groups represented. Individual as well as cumulative scores improved steadily for 6 momths at which time symptomatology was minimal in most patients. Pipotiazine palmitate was well tolerated, and only seven (3.4%) of the 206 patients had to interrupt therapy because of unwanted effects. The most frequent side-effects were e...Continue Reading


Jan 1, 1973·Acta Psychiatrica Scandinavica. Supplementum·U G Ahlfors, O Katila
Jan 1, 1973·Acta Psychiatrica Scandinavica. Supplementum·C Salvesen, K Vaksdal
Jan 1, 1973·Acta Psychiatrica Scandinavica. Supplementum·J Brown-Thomsen
Mar 20, 1971·British Medical Journal·D M LewisG Samuel

Related Concepts

Antipsychotic Effect
Muscle Rigidity
Controlled-Release Preparations
Neurotic Disorders
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Extrapyramidal Sign
Antipsychotic Agents
Psychiatry Specialty

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here